Shenzhen Hepalink Pharmaceutical Group A Logo

Shenzhen Hepalink Pharmaceutical Group A

🇨🇳
002399
CNE100000P02

Shenzhen Hepalink Pharmaceutical Group A is a leading global biotechnology company based in China. It specializes in the development and production of heparin active ingredients and innovative drugs for oncology, autoimmune diseases, and complex therapies.

Next Quarterly Earnings

Saturday, August 29, 2026
CW 35
In 2 days
Confirmed by the company

Date confirmed from the official Chinese exchange disclosure timetable.

Currently in quiet period until August 29, 2026

Stock Price

Frequently asked questions

When will Shenzhen Hepalink Pharmaceutical Group A report its next quarterly earnings?

Shenzhen Hepalink Pharmaceutical Group A is scheduled to report its next quarterly earnings on 08/29/2026.

When did Shenzhen Hepalink Pharmaceutical Group A last report quarterly earnings?

Shenzhen Hepalink Pharmaceutical Group A last reported quarterly earnings on 4/29/2026 (Q1 2026). Earnings per share (EPS) came in at 0.13 CNY.

How do I add the Shenzhen Hepalink Pharmaceutical Group A earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:CN¥0.08
Actual:
Q3 2026
Estimate:CN¥0.20
Actual:
Q1 2026
Estimate:
Actual:CN¥0.13
Price reaction (1 day):-0.1 %
Price reaction (7 days):+1.6 %
Q4 2025
Beat
Estimate:-CN¥0.15
Actual:-CN¥0.14
Difference:+CN¥0.01
Price reaction (1 day):+1.2 %
Price reaction (7 days):+2.4 %

Company Information

Name
Shenzhen Hepalink Pharmaceutical Group A
Ticker Symbol
002399
ISIN
CNE100000P02
Country
🇨🇳
China
Sector